# CHALLENGE PROGRAMME 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections

**Funder:** Novo Nordisk Foundation
**Budget:** DKK 30–75 million per grant
**Duration:** 6 years
**Consortium:** Required — consortium of research partners with a clear vision and mission
**Application:** 2-stage: Stage 1 results December 2026, Stage 2 results June 2027
**Frequency:** One-off
**Eligible countries:** EU, CH, NO, IS, GB
**Official call:** https://novonordiskfonden.dk/en/grant/challenge-programme-2027-advancing-next-generation-amr-diagnostics-for-lower-respiratory-tract-infections/
**Last verified:** 4 July 2026

> **Recently updated:** catalog cleanup 2026-07-04: Oct date was not the published Stage-1 deadline per NNF

## Eligibility & scope

Funds leading researchers forming a consortium to develop innovative solutions in AMR diagnostics for lower respiratory tract infections. Open to international applicants (Research Leaders / Established Professors). Supports Danish and European research ecosystems as a strategic priority of the Novo Nordisk Foundation.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/novo-nordisk-foundation-challenge-programme-2027-advancing-next-generation-2026-10) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.